(Q38970993)

8 September 2017

A novel anti‑cancer effect of resveratrol: reversal of epithelial‑mesenchymal transition in prostate cancer cells (English)

1 reference

8 September 2017

1 reference

Jianping Li

1

1 reference

8 September 2017

Tie Chong

2

1 reference

8 September 2017

Ziming Wang

3

1 reference

8 September 2017

Haiwen Chen

4

1 reference

8 September 2017

Hecheng Li

5

1 reference

8 September 2017

Jun Cao

6

1 reference

8 September 2017

Peng Zhang

7

1 reference

8 September 2017

Hongliang Li

8

1 reference

8 September 2017

23 July 2014

1 reference

Molecular Medicine Reports

8 September 2017

1 reference

8 September 2017

10

1 reference

8 September 2017

4

1 reference

8 September 2017

1717-1724

1 reference

Resveratrol: therapeutic potential for improving cardiometabolic health

8 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148361

Resveratrol inhibits NF-kB signaling through suppression of p65 and IkappaB kinase activities

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148361

Resveratrol inhibits the epithelial-mesenchymal transition of pancreatic cancer cells via suppression of the PI-3K/Akt/NF-κB pathway

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148361

Epithelial-mesenchymal transition (EMT): principles and clinical impact in cancer therapy

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148361

Perspectives on immunotherapy in prostate cancer and solid tumors: where is the future?

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148361

Prostate cancer chemoprevention.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148361

Molecular diagnosis of prostate cancer: are we up to age?

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148361

Regulatory networks defining EMT during cancer initiation and progression

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148361

Emerging roles of PDGF-D in EMT progression during tumorigenesis

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148361

Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148361

Secreted Hsp90 is a novel regulator of the epithelial to mesenchymal transition (EMT) in prostate cancer.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148361

Targeting androgen receptor to suppress macrophage-induced EMT and benign prostatic hyperplasia (BPH) development

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148361

The EMT signaling pathways in endometrial carcinoma.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148361

On translational regulation and EMT.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148361

The anticancer effects of resveratrol: modulation of transcription factors

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148361

Resveratrol: potential as anticancer agent

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148361

EMT as the ultimate survival mechanism of cancer cells

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148361

Shh signal and its functional roles in normal and diseased brain

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148361

What is new for an old molecule? Systematic review and recommendations on the use of resveratrol

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148361

Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148361

Recent advances and developments in treatment strategies against pancreatic cancer

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148361

SHH pathway and cerebellar development

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148361

Cancer chemoprevention with dietary phytochemicals

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148361

Patterning the limb before and after SHH signalling

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148361

Resveratrol inhibits the epidermal growth factor-induced epithelial mesenchymal transition in MCF-7 cells

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148361

Resveratrol inhibits LPS-induced epithelial-mesenchymal transition in mouse melanoma model

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148361

Preparation of resveratrol-enriched grape juice from ultrasonication treated grape fruits.

17 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4148361

[The role of TGF-beta in the EMT of tumor cells]

21 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25069516

12 December 2020

inferred from PubMed ID database lookup

Prostate cancer: androgen deprivation causes EMT in the prostate

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25069516

12 December 2020

inferred from PubMed ID database lookup

[Gli1 expression and its relationship with the expression of Shh, Vimentin and E-cadherin in human hepatocellular carcinoma]

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25069516

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.3892/MMR.2014.2417

1 reference

release_bdi46shp6jedliy5wzb5y65iuu

8 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bdi46shp6jedliy5wzb5y65iuu

24 November 2022

mapped directly with Wikidata item

1 reference

8 September 2017

PubMed publication ID

25069516

1 reference